Nevertheless, a subset of patients experience either persistent hyperparathyroidism, defined as the failure to normalize calcium and parathyroid hormone (PTH) within six months of surgery, or recurrent hyperparathyroidism, defined as the return of hypercalcemia after a period of normocalcemia [3,4]. This evidence concerns the gene PTH and hypercalcemia disease.